Advertisement

Managed Health Care and Utilization of Fecal Occult Blood Testing for Colorectal Cancer Screening: a National Database Study

This is a preview of subscription content, log in to check access.

Access options

Buy single article

Instant unlimited access to the full article PDF.

US$ 39.95

Price includes VAT for USA

Subscribe to journal

Immediate online access to all issues from 2019. Subscription will auto renew annually.

US$ 99

This is the net price. Taxes to be calculated in checkout.

Fig 1.

Abbreviations

HMO:

Health maintenance organization

USPSTF:

United States Preventive Services Task Force

References

  1. 1.

    US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, Curry SJ, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2016;315:2564-2575.

  2. 2.

    White A., Thompson T.D., White M.C., et al: Cancer screening test use—United States, 2015. MMWR Morb Mortal Wkly Rep 2017; 66: pp. 201-206.

  3. 3.

    Jensen CD, Corley DA, Quinn VP, et al. Fecal immunochemical test program over 4 rounds of annual screening: a retrospective study. Ann Intern Med 2016;164:456-63.

  4. 4.

    Baker LC, Phillips KA, Haas JS, Liang SY, Sonneborn D. The effect of area HMO market share on cancer screening. Health Serv Res 2004;39:1751–72.

  5. 5.

    Shariff-Marco S, Breen N, Stinchcomb DG, Klabunde CN. Multilevel predictors of colorectal cancer screening use in California. Am J Manag Care 2013;19(3):205–216.

  6. 6.

    Subramanian S, Tangka FKL, Hoover S, et al. Costs of colorectal cancer screening provision in CDC's Colorectal Cancer Control Program: Comparisons of colonoscopy and FOBT/FIT based screening. Eval Program Plann 2017;62:73-80.

Download references

Author information

Correspondence to Daniel Bushyhead MD.

Ethics declarations

Conflict of Interest

The authors declare that they do not have a conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bushyhead, D., Fishman, P. Managed Health Care and Utilization of Fecal Occult Blood Testing for Colorectal Cancer Screening: a National Database Study. J GEN INTERN MED 35, 357–359 (2020). https://doi.org/10.1007/s11606-019-05504-7

Download citation